QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NYSE:HP

Helmerich & Payne (HP) Stock Forecast, Price & News

$34.86
+2.01 (+6.12%)
(As of 06/7/2023 ET)
Compare
Today's Range
$32.86
$34.93
50-Day Range
$30.88
$38.43
52-Week Range
$30.41
$54.59
Volume
1.99 million shs
Average Volume
1.51 million shs
Market Capitalization
$3.58 billion
P/E Ratio
11.47
Dividend Yield
2.87%
Price Target
$52.90

Helmerich & Payne MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
51.7% Upside
$52.90 Price Target
Short Interest
Healthy
4.93% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-8.40
Upright™ Environmental Score
News Sentiment
0.38mentions of Helmerich & Payne in the last 14 days
Based on 23 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-0.48%
From $4.16 to $4.14 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.31 out of 5 stars

Oils/Energy Sector

123rd out of 244 stocks

Drilling Oil & Gas Wells Industry

3rd out of 11 stocks


HP stock logo

About Helmerich & Payne (NYSE:HP) Stock

Founded in 1920, Helmerich & Payne, Inc. (H&P) (NYSE: HP) is committed to delivering industry leading levels of drilling productivity and reliability. H&P operates with the highest level of integrity, safety and innovation to deliver superior results for its customers and returns for shareholders. Through its subsidiaries, the Company designs, fabricates and operates high-performance drilling rigs in conventional and unconventional plays around the world. H&P also develops and implements advanced automation, directional drilling and survey management technologies. H&P’s fleet includes 299 land rigs in the U.S., 31 international land rigs and eight offshore platform rigs.

Receive HP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helmerich & Payne and its competitors with MarketBeat's FREE daily newsletter.

HP Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Helmerich & Payne (NYSE: HP)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
8 Analysts Have This to Say About Helmerich & Payne
Helmerich & Payne (NYSE:HP) PT Lowered to $52.00
Barclays Reaffirms Their Buy Rating on Helmerich & Payne (HP)
See More Headlines

HP Price History

HP Company Calendar

Last Earnings
1/31/2023
Ex-Dividend for 6/1 Dividend
5/17/2023
Dividend Payable
6/01/2023
Today
6/07/2023
Next Earnings (Estimated)
7/26/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Drilling oil & gas wells
Sub-Industry
Oil & Gas Drilling
CUSIP
42345210
Employees
7,000
Year Founded
1920

Price Target and Rating

Average Stock Price Forecast
$52.90
High Stock Price Forecast
$71.00
Low Stock Price Forecast
$33.00
Forecasted Upside/Downside
+51.9%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
10 Analysts

Profitability

Net Income
$6.95 million
Pretax Margin
16.31%

Debt

Sales & Book Value

Annual Sales
$2.06 billion
Cash Flow
$4.21 per share
Book Value
$26.26 per share

Miscellaneous

Free Float
98,317,000
Market Cap
$3.57 billion
Optionable
Optionable
Beta
1.66

Social Links


Key Executives

  • Mr. John W. LindsayMr. John W. Lindsay (Age 58)
    Pres, CEO & Director
  • Mr. Mark W. Smith CPA (Age 48)
    VP, CFO, Treasurer & Director
  • Ms. Cara M. Hair (Age 43)
    VP of Corp. Services, Chief Legal & Compliance Officer
  • Mr. Robert L. Stauder (Age 56)
    Sr. VP & Chief Engineer of Helmerich & Payne International Drilling Co
  • Mr. Dave Wilson
    Director of Investor Relations













HP Stock - Frequently Asked Questions

Should I buy or sell Helmerich & Payne stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Helmerich & Payne in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HP shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HP, but not buy additional shares or sell existing shares.
View HP analyst ratings
or view top-rated stocks.

What is Helmerich & Payne's stock price forecast for 2023?

10 analysts have issued 1 year price objectives for Helmerich & Payne's stock. Their HP share price forecasts range from $33.00 to $71.00. On average, they predict the company's share price to reach $52.90 in the next year. This suggests a possible upside of 51.9% from the stock's current price.
View analysts price targets for HP
or view top-rated stocks among Wall Street analysts.

How have HP shares performed in 2023?

Helmerich & Payne's stock was trading at $49.57 at the start of the year. Since then, HP stock has decreased by 29.8% and is now trading at $34.82.
View the best growth stocks for 2023 here
.

Are investors shorting Helmerich & Payne?

Helmerich & Payne saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 4,870,000 shares, a drop of 24.8% from the April 30th total of 6,480,000 shares. Based on an average daily trading volume, of 1,620,000 shares, the days-to-cover ratio is currently 3.0 days. Currently, 4.9% of the shares of the company are sold short.
View Helmerich & Payne's Short Interest
.

When is Helmerich & Payne's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our HP earnings forecast
.

How were Helmerich & Payne's earnings last quarter?

Helmerich & Payne, Inc. (NYSE:HP) posted its quarterly earnings data on Tuesday, January, 31st. The oil and gas company reported $1.11 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.30. The oil and gas company earned $719.60 million during the quarter, compared to analyst estimates of $699.92 million. Helmerich & Payne had a trailing twelve-month return on equity of 11.93% and a net margin of 12.15%. Helmerich & Payne's revenue was up 75.6% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.45) earnings per share.

How often does Helmerich & Payne pay dividends? What is the dividend yield for Helmerich & Payne?

Helmerich & Payne declared a quarterly dividend on Wednesday, March 1st. Investors of record on Thursday, May 18th will be paid a dividend of $0.485 per share on Thursday, June 1st. This represents a $1.94 dividend on an annualized basis and a dividend yield of 5.57%. The ex-dividend date is Wednesday, May 17th.
Read our dividend analysis for HP
.

Is Helmerich & Payne a good dividend stock?

Helmerich & Payne (NYSE:HP) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.06%. The dividend payout ratio is 32.89%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HP will have a dividend payout ratio of 24.15% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HP.

What is John Lindsay's approval rating as Helmerich & Payne's CEO?

97 employees have rated Helmerich & Payne Chief Executive Officer John Lindsay on Glassdoor.com. John Lindsay has an approval rating of 92% among the company's employees. This puts John Lindsay in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Helmerich & Payne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Helmerich & Payne investors own include AT&T (T), CA (CA), Exxon Mobil (XOM), Johnson & Johnson (JNJ), Pfizer (PFE), Verizon Communications (VZ), Boeing (BA), Intel (INTC), Cisco Systems (CSCO) and Gilead Sciences (GILD).

What is Helmerich & Payne's stock symbol?

Helmerich & Payne trades on the New York Stock Exchange (NYSE) under the ticker symbol "HP."

Who are Helmerich & Payne's major shareholders?

Helmerich & Payne's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (17.46%), Dimensional Fund Advisors LP (4.86%), State Street Corp (4.23%), Van ECK Associates Corp (2.45%), Boston Trust Walden Corp (2.04%) and Geode Capital Management LLC (1.93%). Insiders that own company stock include Hans Helmerich, John R Bell, John W Lindsay, Michael Lennox, Raymond John Adams III, Sara Marie Momper and Todd Willard Benson.
View institutional ownership trends
.

How do I buy shares of Helmerich & Payne?

Shares of HP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Helmerich & Payne's stock price today?

One share of HP stock can currently be purchased for approximately $34.82.

How much money does Helmerich & Payne make?

Helmerich & Payne (NYSE:HP) has a market capitalization of $3.57 billion and generates $2.06 billion in revenue each year. The oil and gas company earns $6.95 million in net income (profit) each year or $3.04 on an earnings per share basis.

How many employees does Helmerich & Payne have?

The company employs 7,000 workers across the globe.

How can I contact Helmerich & Payne?

Helmerich & Payne's mailing address is 1437 SOUTH BOULDER AVENUE SUITE 1400, TULSA OK, 74119. The official website for the company is www.hpinc.com. The oil and gas company can be reached via phone at 918-742-5531, via email at investor.relations@hpinc.com, or via fax at 918-742-0237.

This page (NYSE:HP) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -